News

StockStory.org on MSN1d
Organon (NYSE:OGN) Posts Better-Than-Expected Sales In Q1 But Stock Drops 23.5%
Pharmaceutical company Organon (NYSE:OGN) reported in Q1 CY2025, but sales fell by 6.7% year on year to $1.51 billion. Its ...
StockStory.org on MSN21h
Reflecting On Apparel Retailer Stocks’ Q4 Earnings: Abercrombie and Fitch (NYSE:ANF)
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...
Stockhouse8d
AGCO Leader Wins 2025 Women MAKE Award
DULUTH, Ga., April 25, 2025 /PRNewswire/ -- AGCO (NYSE: AGCO), a global leader in the design, manufacture and distribution of agricultural machinery and precision ag technology, is proud to announce ...
Yahoo Finance24d
Q4 Earnings Roundup: Organon (NYSE:OGN) And The Rest Of The Branded Pharmaceuticals Segment
Spun off from Merck in 2021 to create a company dedicated to addressing unmet needs in women's health, Organon (NYSE:OGN) is a global healthcare company focused on improving women's health through ...